Chammas & Marcheteau has advised Iris in the transaction. Popsink has closed a €3 million fundraising round, with Iris serving as the lead investor. The capital...
You must be a Standard 1 Year member to access this content.
Chammas & Marcheteau has advised AfricInvest Europe on the first closing of Fonds Franco-Africain 3. AfricInvest Europe, the management company of the pan-African AfricInvest Group, has...
You must be a Standard 1 Year member to access this content.
Chammas & Marcheteau advised Yotta Capital Partners on its acquisition of a majority stake in SEDI-ATI. Yotta Capital Partners, the leading French investment fund dedicated to...
You must be a Standard 1 Year member to access this content.
Chammas & Marcheteau advised a consortium of investment funds. The sellers were advised by Lamartine Conseil. The management was advised by Lamartine Conseil. The senior lenders...
You must be a Standard 1 Year member to access this content.
Chammas & Marcheteau advised Xelya and the sellers in the framework of the OBO. Goodwin and MB Avocats advised Parquest. The founders of Xelya, together with...
You must be a Standard 1 Year member to access this content.
Osborne Clarke advised Treatwell France on the deal. Chammas & Marcheteau advised Wavy. The Treatwell group – the leading beauty and wellness site and app in...
You must be a Standard 1 Year member to access this content.
Chammas & Marcheteau advised Turenne Capital on the deal while Bird & Bird represented Domain Therapeutics. Jones Day advised CTI Life Sciences Fund, Panacea Venture, and...
You must be a Standard 1 Year member to access this content.
Chammas & Marcheteau advised Turenne Capital on the deal. Lavery de Billy and Bird & Bird represented Domain Therapeutics. Jones Day advised CTI Life Sciences Fund,...
You must be a Standard 1 Year member to access this content.
